We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
-26.28%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
AUM
$343M
AUM Growth
-$482M
Cap. Flow
-$322M
Cap. Flow %
-93.72%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
2
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RELX icon
RELX
RELX
+$182M
2
ILMN icon
Illumina
ILMN
+$137M
3
LYEL icon
Lyell Immunopharma
LYEL
+$1.52M
4
BEAM icon
Beam Therapeutics
BEAM
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.74B
$187M 54.51%
2,346,934
-15,701
-0.7% -$1.34M
LYEL icon
2
Lyell Immunopharma
LYEL
$315M
$156M 45.49%
1,008,117
-6,809
-0.7% -$1.52M
ILMN icon
3
Illumina
ILMN
$28.9B
-346,541
Closed -$137M
RELX icon
4
RELX
RELX
$57.2B
-40,254,832
Closed -$182M

Similar funds

MWG Management's Q4 2021 Portfolio in Review

As of Q4 2021, MWG Management held 4 positions worth $343M, down 58% from $825M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MWG Management withdrew a net $322M in Q4 2021, closing 2 positions and reducing 2 holdings. Its most notable exit was RELX, an estimated $182M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 78% a quarter earlier, followed by Industrials.

  • MWG Management's biggest Q4 2021 reduction was Lyell Immunopharma, cutting an estimated $1.52M.
  • MWG Management fully exited RELX in Q4 2021, selling an estimated $182M.
  • MWG Management's ten largest holdings make up 100% of its $343M portfolio in Q4 2021.
  • MWG Management opened 0 new positions and closed 2 in Q4 2021.
  • MWG Management's portfolio value fell 58% quarter-over-quarter to $343M.

Based on MWG Management's 13F filing for Q4 2021, filed 14 Feb 2022.